P2X7 receptor activation impairs antitumour activity of natural killer cells-Reference-Cited by-同舟云学术

P2X7 receptor activation impairs antitumour activity of natural killer cells

Published:2022-10-03 Issue:1 Volume:180 Page:111-128
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:British J Pharmacology

Author:

Baroja‐Mazo Alberto¹^ORCID,Peñín‐Franch Alejandro¹,Lucas‐Ruiz Fernando¹,de Torre‐Minguela Carlos¹,Alarcón‐Vila Cristina¹,Hernández‐Caselles Trinidad¹²,Pelegrín Pablo¹²

Affiliation:

1. Biomedical Research Institute of Murcia (IMIB‐Pascual Parrilla) University Clinical Hospital Virgen de la Arrixaca Murcia Spain

2. Department of Biochemistry and Molecular Biology B and Immunology, Faculty of Medicine University of Murcia Murcia Spain

Funder

H2020 European Research Council

Instituto de Salud Carlos III

Fundación Séneca

Fundación Mutua Madrileña

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bph.15951

Reference72 articles.

1. Basal Activation of the P2X7 ATP Receptor Elevates Mitochondrial Calcium and Potential, Increases Cellular ATP Levels, and Promotes Serum-independent Growth

2. Accelerated Tumor Progression in Mice Lacking the ATP Receptor P2X7

3. P2X7 receptor: Death or life?

4. THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Nuclear hormone receptors

5. THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Ion channels;Alexander S. P.;British Journal of Pharmacology,2021

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of the P2X7 receptor on the tumor immune microenvironment and its effects on tumor progression;Biochemical and Biophysical Research Communications;2024-05

2. Hypoxic tumor microenvironment: Destroyer of natural killer cell function;Chinese Journal of Cancer Research;2024

3. Purinergic P2X Receptors as Therapeutic Targets;Ion Channels as Targets in Drug Discovery;2024

4. Tumour immune escape via P2X7 receptor signalling;Frontiers in Immunology;2023-10-30

5. A Species-Specific Anti-Human P2X7 Monoclonal Antibody Reduces Graft-versus-Host Disease in Humanised Mice;Pharmaceutics;2023-08-31